Contracts › 75N91021F00002
75N91021F00002: Project Title: Further Evaluation of AMHR2-ED Antigens for Epithelial Ovarian Carcinoma
Awarded to University of Oklahoma by National Institutes of Health (NIH).
$1.0Mobligated
$1.0Mpotential value
14 September 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N91021F00002 |
|---|---|
| Vehicle | 75N91019D00020 |
| Awardee | University of Oklahoma |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NIH NCI |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | OK |
| Offers received | 1 |
| Period of performance | 15 September 2021 to 14 September 2026 |
| Potential end | 14 September 2026 |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record